Jagat Narula, MD, PhD: A conversation with the editor
Dr. Narula was born in Ajmer, India, on July 16, 1956. He graduated from Sawai Mansingh (SMS) Medical College in Jaipur, India, in 1978, where he also completed his training…
Effects of P2Y12 Receptor Inhibition in Patients With ST-Segment Elevation Myocardial Infarction
In ST-segment elevation myocardial infarction (STEMI), an effective antiplatelet treatment adjunctive to primary percutaneous coronary intervention is of utmost importance. High dose of clopidogrel, prasugrel, or ticagrelor provides a faster,…
Relation of Long-Term Exposure to Air Pollution to Brachial Artery Flow-Mediated Dilation and Reactive Hyperemia
Long-term exposure to ambient air pollution has been associated with cardiovascular morbidity and mortality. Impaired vascular responses may, in part, explain these findings, but the association of such long-term exposure…
Concerning Antiplatelet Therapy
I read the report by Migliorini et al. The report concludes “prasugrel is associated with increased inhibition of platelet aggregation and with a better clinical outcome than is clopidogrel.” I would…
The Björk-Shiley Convexo-Concave Heart Valve Experience from the Perspective of the Supervisory Panel
The report by Harrison et al clinically informs the developmental events of Pfizer’s Björk-Shiley convexo-concave (BSCC) valve to date. I would like to present the other side of the story from…
Role of Epicardial Fat in Atrial Fibrillation After Coronary Artery Bypass Surgery
We read the work by Shimony et al published in a recent issue of The American Journal of Cardiology . Their work is commendable and describes a novel risk predictor for…
Dabigatran in Catheter Ablation of Atrial Fibrillation: A Call for a Randomized Control Trial
We read the study by Sardar et al entitled Meta-Analysis of Risk of Stroke or Transient Ischemic Attack With Dabigatran for Atrial Fibrillation Ablation . Sardar et al have conducted a rigorous…
Eighth Joint National Committee: Evidence Versus Eminence
The authors start out with the very promising statement “This report takes a rigorous, evidence-based approach to recommended treatment thresholds, goals and medications in the management of hypertension in adults.” Given that within 1…
